Our
Achievements - Product Launches
Ranbaxy Pharmaceuticals Inc. (RPI) is one of the fastest growing
pharmaceutical companies in the U.S. generic pharmaceutical
market. The Company’s phenomenal growth is due to an innate
ability to establish and thrive in a wide array of market conditions.
Submitting more than 20 ANDAs to the U.S. FDA each year, the
company is continually launching new products. Ranbaxy’s
healthy pipeline is also an indication of consistent and significant
growth in the future.
Our Alliances
Ranbaxy Pharmaceuticals Inc. (RPI) has developed strategic alliances
with other generic and branded pharmaceutical companies, and
is leveraging the synergies that result from partnering with
these organizations.
These alliances are primarily co-marketing or co-development
arrangements for common products with other organizations.
Ranbaxy is an open, creative, action-oriented organization that
is receptive to discussions with any company that may have complementary
skills, goals or business interests.
|
